Literature DB >> 16310513

Influence of hypoalbuminemia or hyperalbuminemia on the serum anion gap.

Mark Feldman1, Nilam Soni, Beverly Dickson.   

Abstract

BACKGROUND: Conflicting data exist as to what extent hypoalbuminemia reduces the anion gap; estimates range from 1.5 to 2.5 mM per g/dL decrease in serum albumin.
METHODS: We measured serum albumin, total protein, and electrolyte concentrations in 5328 consecutive patients aged 1 month to 102 years. Most patients (3750; 70%) had a normal albumin, but 1158 had hypoalbuminemia (< or =3.4 g/dL); 420 had hyperalbuminemia (> or =4.7 g/dL). Relationships between serum albumin or total protein and the anion gap were analyzed by linear regression.
RESULTS: 309 (27%) hypoalbuminemic patients had a decreased anion gap, and 257 hyperalbuminemic patients (61%) had an increased anion gap. Among the entire group of 5328 patients, there were highly significant correlations between either serum albumin or total protein and the anion gap (P < 0.001). The slope of the regression for albumin versus anion gap was 2.3 mM per g/dL. Using this slope, anion gap could be adjusted for abnormal serum albumin levels: anion gap(adjusted) =anion gap + 2.3 (4-albumin). The initial assessment of an anion gap as being increased, normal, or decreased changed in 44% of the patients with hypo- or hyperalbuminemia once anion gap had been adjusted with this formula.
CONCLUSIONS: Before considering whether a disorder associated with an increased or decreased anion gap is present, the anion gap should be first adjusted for abnormal serum albumin concentrations. Our data suggest that physicians use 2.3 times the change in serum albumin, whereas those of Figge et al suggest 2.5; either approach gives similar results.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16310513     DOI: 10.1016/j.lab.2005.07.008

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  21 in total

Review 1.  The serum anion gap in the evaluation of acid-base disorders: what are its limitations and can its effectiveness be improved?

Authors:  Jeffrey A Kraut; Glenn T Nagami
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 8.237

2.  Misdiagnosis of high anion gap acidosis owing to instrument error of a device.

Authors:  Masayuki Tanemoto; Seiki Yamada; Takahide Kimura; Takeshi Yokoyama; Yukio Okazaki
Journal:  CEN Case Rep       Date:  2019-08-29

Review 3.  Pharmacologically-induced metabolic acidosis: a review.

Authors:  George Liamis; Haralampos J Milionis; Moses Elisaf
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

4.  The brain metabolic activity after resuscitation with liposome-encapsulated hemoglobin in a rat model of hypovolemic shock.

Authors:  Geeta Rao; Andria F Hedrick; Vivek R Yadav; Jun Xie; Alamdar Hussain; Vibhudutta Awasthi
Journal:  J Cereb Blood Flow Metab       Date:  2015-05-06       Impact factor: 6.200

5.  Paediatric acid-base disorders: A case-based review of procedures and pitfalls.

Authors:  J Bryan Carmody; Victoria F Norwood
Journal:  Paediatr Child Health       Date:  2013-01       Impact factor: 2.253

6.  The anion gap and routine serum protein measurements in monoclonal gammopathies.

Authors:  Karen H van Hoeven; Rosy E Joseph; William J Gaughan; Laura McBride; Elizabeth Bilotti; Ann McNeill; Linda Schmidt; Danielle Schillen; David S Siegel
Journal:  Clin J Am Soc Nephrol       Date:  2011-12       Impact factor: 8.237

Review 7.  Drug-induced acid-base disorders.

Authors:  Daniel Kitterer; Matthias Schwab; M Dominik Alscher; Niko Braun; Joerg Latus
Journal:  Pediatr Nephrol       Date:  2014-11-05       Impact factor: 3.714

8.  Delivery of sphingosine 1-phosphate from poly(ethylene glycol) hydrogels.

Authors:  Bradley K Wacker; Evan A Scott; Megan M Kaneda; Shannon K Alford; Donald L Elbert
Journal:  Biomacromolecules       Date:  2006-04       Impact factor: 6.988

Review 9.  Metabolic acidosis: pathophysiology, diagnosis and management.

Authors:  Jeffrey A Kraut; Nicolaos E Madias
Journal:  Nat Rev Nephrol       Date:  2010-03-23       Impact factor: 28.314

10.  Hemorrhagic shock-induced cerebral bioenergetic imbalance is corrected by pharmacologic treatment with EF24 in a rat model.

Authors:  Geeta Rao; Jun Xie; Andria Hedrick; Vibhudutta Awasthi
Journal:  Neuropharmacology       Date:  2015-07-29       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.